STEFANI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 22.027
EU - Europa 12.806
AS - Asia 11.423
SA - Sud America 2.077
AF - Africa 1.227
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 17
AN - Antartide 2
Totale 49.604
Nazione #
US - Stati Uniti d'America 21.123
SG - Singapore 5.966
RU - Federazione Russa 3.458
IT - Italia 3.313
CN - Cina 3.046
IE - Irlanda 1.810
BR - Brasile 1.785
UA - Ucraina 1.597
VN - Vietnam 856
CA - Canada 701
CI - Costa d'Avorio 631
FR - Francia 605
DE - Germania 579
KR - Corea 307
SE - Svezia 306
GB - Regno Unito 299
NG - Nigeria 242
IN - India 241
FI - Finlandia 194
BD - Bangladesh 174
AR - Argentina 116
MX - Messico 114
SN - Senegal 101
ES - Italia 98
IQ - Iraq 98
PL - Polonia 94
HK - Hong Kong 90
NL - Olanda 90
TR - Turchia 84
ZA - Sudafrica 83
JP - Giappone 82
BE - Belgio 73
ID - Indonesia 70
PK - Pakistan 63
CH - Svizzera 57
UZ - Uzbekistan 56
AT - Austria 53
EC - Ecuador 42
VE - Venezuela 35
GR - Grecia 34
BJ - Benin 31
MA - Marocco 30
AE - Emirati Arabi Uniti 29
JO - Giordania 28
IR - Iran 27
KE - Kenya 27
LB - Libano 26
CO - Colombia 24
DZ - Algeria 22
SA - Arabia Saudita 22
UY - Uruguay 22
IL - Israele 21
JM - Giamaica 21
KZ - Kazakistan 21
AU - Australia 20
EG - Egitto 18
MY - Malesia 18
LT - Lituania 17
NO - Norvegia 17
PY - Paraguay 17
RO - Romania 17
NP - Nepal 16
TN - Tunisia 16
CL - Cile 14
PH - Filippine 14
CR - Costa Rica 13
NI - Nicaragua 13
CZ - Repubblica Ceca 12
EU - Europa 12
BO - Bolivia 11
PE - Perù 11
BG - Bulgaria 10
HN - Honduras 10
OM - Oman 9
HR - Croazia 8
PA - Panama 8
SY - Repubblica araba siriana 8
AZ - Azerbaigian 7
BY - Bielorussia 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
HU - Ungheria 7
KG - Kirghizistan 7
AO - Angola 6
BH - Bahrain 6
DK - Danimarca 6
MD - Moldavia 6
PT - Portogallo 6
RS - Serbia 6
AL - Albania 5
MT - Malta 5
TT - Trinidad e Tobago 5
AM - Armenia 4
BB - Barbados 4
NZ - Nuova Zelanda 4
XK - ???statistics.table.value.countryCode.XK??? 4
BN - Brunei Darussalam 3
CG - Congo 3
CY - Cipro 3
EE - Estonia 3
Totale 49.547
Città #
Dallas 3.443
Singapore 3.401
Santa Clara 2.518
Dublin 1.807
San Jose 1.733
Chandler 1.653
Jacksonville 1.631
Moscow 1.364
Ashburn 1.138
Boardman 769
Catania 763
Chicago 633
Abidjan 631
Los Angeles 491
Nanjing 488
Lawrence 486
Cambridge 484
Andover 473
Lauterbourg 472
Hefei 454
Toronto 449
Beijing 426
Houston 423
Seoul 307
Des Moines 283
Ho Chi Minh City 283
San Mateo 249
Munich 233
New York 205
Civitanova Marche 194
Council Bluffs 189
Hanoi 187
São Paulo 187
Messina 178
Wilmington 176
Nanchang 155
Hebei 148
Bremen 140
Buffalo 140
Shenyang 137
Rome 131
Palermo 125
Lagos 124
Saint Petersburg 118
Jiaxing 113
Helsinki 106
Ottawa 106
Dakar 101
Changsha 97
Abuja 95
Montreal 91
Belpasso 89
Tianjin 83
Grafing 82
Orem 81
Hong Kong 79
Tokyo 78
Milan 76
The Dalles 74
Brussels 72
Seattle 67
Warsaw 67
Columbus 65
Lappeenranta 65
Rio de Janeiro 58
Brooklyn 57
Johannesburg 54
Phoenix 54
Chennai 53
London 53
Denver 49
Atlanta 46
Haiphong 46
Stockholm 46
Mexico City 45
Amsterdam 43
Boston 42
Baghdad 39
Brolo 38
Dong Ket 38
Syracuse 38
Acireale 37
Poplar 37
San Francisco 37
Washington 36
Brasília 34
Da Nang 34
Reggio Calabria 33
Belo Horizonte 32
Curitiba 32
Hangzhou 32
Cotonou 31
Falls Church 30
Frankfurt am Main 29
Kunming 29
Tashkent 29
Ankara 27
Amman 26
Manchester 26
Naples 26
Totale 33.102
Nome #
Update on screening and clinical diagnosis of meticillin-resistant Staphylococcus aureus (MRSA) 380
A Snapshot of the COL-R Acinetobacter baumannii Comparative Transcriptome by RNA-seq. 315
Balancing the Virulence and Antimicrobial Resistance in VISA DAP-R CA-MRSA Superbug 312
Guida alla determinazione delle alghe del Mediterraneo. Parte I: Alghe azzurre (Cyanophyta o Cyanobacteria) 306
Gut Microbiota and Cancer: From Pathogenesis to Therapy 259
Attività antibatterica di netilmicina e netilmicina/desametasone, in paragone con altri antibiotici, verso Gram-positivi e Gram-negativi isolati da infezioni oculari. 192
Bactericidal activity of Ceftobiprole combined with different antibiotics against selected gram-positive isolates 185
Antimicrobial properties of Lactobacillus cell-free supernatants against multidrug-resistant urogenital pathogens 185
A multicenter study on central venous catheter-associated infections in Italy 180
A novel delta-hemolysis screening method for detecting heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-inermediate S.aureus 179
Potential associations among alteration of salivary mirnas, saliva microbiome structure, and cognitive impairments in autistic children 179
A Clinical protocol for safety and colonization in human rhinopharynx by S.salivarius 24SMBc 177
Single-nucleotide polymorphism and downstream signaling associated with chronic rhinosinusitis, asthma, allergy and acetylsalicylic-acid intolerance: a narrative review 176
Ceftazidime-Avibactam Treatment for Klebsiella pneumoniae Bacteremia in Preterm Infants in NICU: A Clinical Experience 172
Ability of osteoblast invasion of rifampicin- methicillin-resistant Staphylococcus aureus isolates 171
Computational modeling of immunologic response to immune checkpoint inhibitors in COVID-19 patients with and without cancer 170
Emergence of two novel sequence types (3366 and 3367) NDM-1- and OXA-48-co-producing K. pneumoniae in Italy 170
Interactions of Gram-Positive Bacterial Membrane Vesicles and Hosts: Updates and Future Directions 166
Heteroaryl-Ethylenes as New Effective Agents for High Priority Gram-Positive and Gram-Negative Bacterial Clinical Isolates 162
Colistin Resistant A. baumannii: Genomic and Transcriptomic Traits Acquired Under Colistin Therapy 162
Bactericidal and synergistic activity of ceftobiprole combined with different antibiotics against selected Gram-positive isolates 160
Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and β-haemolytic streptococci collected from western European countries in 2011 160
Different modulatory effects of four methicillin‐resistant Staphylococcus aureus clones on MG-63 osteoblast-like cells 160
Streptococcus salivarius 24SMBc Genome Analysis Reveals New Biosynthetic Gene Clusters Involved in Antimicrobial Effects on Streptococcus pneumoniae and Streptococcus pyogenes 159
A new reliable screening method for the evaluation of VISA and hVISA strains by “Vancomycin-Teicoplanin MIC Test Strip” (VTMTS) (Liofilchem srl, Italy). 158
"USO DI STREPTOCOCCUS SALIVARIUS NEL TRATTAMENTO DELLE INFEZIONI CRONICHE DEL TRATTO RESPIRATORIO" 157
A clinical study comparing ofloxacin (0,3%) with tobramycin (0,3%), for th tretment of external ocular infection 156
Burkholderia cepacia complex in cystic fibrosis and non cystic fibrosis patients: identification of a cluster of epidemic lineages 156
A bioinformatic approach to microbial proteome analysis 156
Burden of Rifampicin- and Methicillin-Resistant Staphylococcus aureus in Italy. 155
Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability 154
Agr-Genotyping and transcriptional analysis of biofilm-producing Staphylococcus aureus 153
Active surveillance of invasive pneumococcal diseases in Sicilian children (2009-2011) Working group: Abate C, Allù M, Arena M, Armenia FR, Barberi I, Barraco G, Belbruno F, Bozzanca L, Bruno G, Canzeroni G, Casà C, Casuccio N, Contrino L, Cuccia M, Cavaleri G, D'Angelo R, Di Naro S, Di Stefano P, Dones P, Emma F, Falsaperla R, Ferrera G, Geraci G, Ghiraldi E, Gramaglia G, Iacono F, Incorpora, Lizzio A, Madonia S, Malato C, Marcantonio G, Margani S, Merlino F, Nicastro L, Palillo L, Pavone P, Porto A, Puglisi G, Rotondo A, Salvo V, Santagati M.C., Santangelo C, Sferrazza I, Stassi G, Tumminelli F, Varvaro A, Vitale M. 152
Microbiome differences in periodontal, peri-implant, and healthy sites: a cross-sectional pilot study 151
A new reliable screening method for the evaluation of VISA and hVISA strains by “Vancomycin-Teicoplanin MIC Test Strip” (VTMTS) 150
ACTION OF CLINDAMYCIN-PHOSPHATE IN FOREIGN-BODY INFECTIONS DUE TO STAPHYLOCOCCUS-EPIDERMIDIS IN MICE 150
CovidTGI: A tool to investigate the temporal genetic instability of SARS-CoV-2 variants 148
Discriminatory Weight of SNPs in Spike SARS-CoV-2 Variants: A Technically Rapid, Unambiguous, and Bioinformatically Validated Laboratory Approach 148
The Rapid Phenotypic Susceptibility Testing in Real-Life Experience: How the MIC Values Impact on Sepsis Fast Diagnostic Workflow 147
Aspetti Microbiologici e legislativi delle piscine:valutazione dell’azione batterica di due disinfettanti a base di cloro, comunemente utilizzati in piscina 147
Unveiling the Secrets of Acinetobacter baumannii: Resistance, Current Treatments, and Future Innovations 145
Attività antibatterica in vitro dell’associazione thrimethoprim/sulfadiazina 143
Testing surgical face masks in an emergency context: The experience of italian laboratories during the COVID-19 pandemic crisis 143
Analysis of polycystic kidney disease with two new microsatellite markers 142
Added value of multi-pathogen probe-based real-time PCR SeptiFast in the rapid diagnosis of bloodstream infections in patients with bacteraemia. 141
Activity of Tigecycline against well characterized multi-resistant Gram-positive strains 141
VISA CA-MRSA Transcriptomic Adaptations Emerging Under Teicoplanin Therapy 140
Ceftazidime/Avibactam and Meropenem/Vaborbactam for the Management of Enterobacterales Infections: A Narrative Review, Clinical Considerations, and Expert Opinion 140
A contribute on the fosfomycin mechanism of resistance in MDR organisms 139
Cefditoren versus community acquired respiratory pathogens: time kill studies 139
Detection of methicillin-resistant Staphylococcus aureus persistence in osteoblasts using imaging flow cytometry 139
Antibiotico-resistenza, Genomovar Status e Distribuzione di markers di patogenicità in Burkholderia cepacia complex 138
AF141943 - Haemophilus parainfluenzae 16S/23S long rRNA spacer region; tRNA-Ile and tRNA-Ala genes, complete sequences 138
Antipneumococcal activity of telithromycin in comparison with other drugs in relation to the presence of different resistance genes 138
Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study 138
Combination of aztreonam, ceftazidime–avibactam and amikacin in the treatment of VIM-1 Pseudomonas aeruginosa ST235 osteomyelitis 138
Attività in vitro di tigeciclina e altri antibiotici verso Acinetobacter baumannii isolati da infezioni gravi in Italia 137
44 Oral streptococci producing bacteriocin-like inhibitory substances (BLIS) as oral probiotics against potential upper respiratory tract pathogens 137
Activity of telithromycin against multi-drug resistant Streptococcus pneumoniae and molecular characterization of macrolide and tetracycline resistance determinants 137
Application of bacteriotherapy in human rhinopharynx 137
Prediction of antimicrobial resistance of Klebsiella pneumoniae from genomic data through machine learning 136
Genomic characterization of a new biofilm-forming and adhesive st398 human-adapted mssa lineage causing septic knee arthritis following surgical reconstruction 136
Berberine-styrene-co-maleic acid nanomicelles: unlocking opportunities for the treatment and prevention of bacterial infections 135
Omic insights into various ceftazidime-avibactam-resistant Klebsiella pneumoniae isolates from two southern Italian regions 135
Cell-free supernatant of Lactobacillus gasseri 1A-TV shows a promising activity to eradicate carbapenem-resistant Klebsiella pneumoniae colonization 135
PD-1, PD-L1 and cAMP immunohistochemical expressions are associated with worse oncological outcome in patients with bladder cancer 134
Oregano and Thyme Essential Oils Encapsulated in Chitosan Nanoparticles as Effective Antimicrobial Agents against Foodborne Pathogens 134
Evaluation of the Effects of Heteroaryl Ethylene Molecules in Combination with Antibiotics: A Preliminary Study on Control Strains 132
"USO DI STREPTOCOCCUS SALIVARIUS NEL TRATTAMENTO DI MALATTIE DEL TRATTO RESPIRATORIO" 132
Eventi avversi e trigger C12: Stroke in ospedale 132
Colonization and persistence of S.salivarius 24 SMBc in human rhinopharynx 131
Antibacterial activity of PZ-601 against well-characterized and recent clinical isolates of methicillin-resistant Staphylococcus aureus 131
Deciphering DAP and Glycopeptide mechanism of action-related transcriptome profiling by RNA-seq in S.aureus. 130
Change in daptomycin killing activity in MRSA clones under vancomycin challenge 130
agr-genotyping of biofilm producing Staphylococcus aureus 130
AGR DEFICIENCY AND EXPRESSION CHANGES IN REGULATORY AND CELL WALL GENES RESPONSIBLE FOR HVISA AND VISA PHENOTYPES 130
Colistin Increases the Cidal Activity of Antibiotic Combinations Against Multidrug-Resistant Klebsiella pneumoniae: An In Vitro Model Comparing Multiple Combination Bactericidal Testing at One Peak Serum Concentration and Time-Kill Method. 130
A multicenter performance evaluation of cefiderocol MIC results: ComASP in comparison to CLSI broth microdilution 129
Staphylococcus aureus ST228 and ST239 as models for expression studies of diverse markers during osteoblast infection and persistence 129
Gain-in omic signatures of colistin-resistant Acinetobacter baumannii undergoing colistin therapy. 128
Heteroaryl-ethylenes as new effective agents in the fight against high priority Gram-positive and Gram-negative bacterial clinical isolates 128
Study of a melanic pigment of Proteus mirabilis 128
Extensively drug-resistant ArmA-producing Acinetobacter baumannii in an Italian intensive care unit 128
BURKHOLDERIA GLADIOLI, A BIOCONTROL AGENT AGAINST GREEN AND BLU MOLD OF FRUITS 128
Infections with VIM-1 metallo beta-lactamase producing Enterobacter cloacae and their correlation with clinical outcome 127
Heteroresistance to glycopeptides in Italian methicillin-resistant Staphylococcus aureus (MRSA) isolates 127
CHEESE MAKING USING WOODENEQUIPMENT PROMOTE BIOFILM FORMATION BY S AUREUS 127
Antibacterial activity of netilmicin and netilmicin/desametasone fixed combination against the most common ocular isolates 127
CRISPR-Cas system molecular organization and functionality in clinical MDR Staphylococcus epidermidis. 126
Modulating Activity of Vancomycin and Daptomycin on the Expression of Autolysis Cell-Wall Turnover and Membrane Charge Genes in hVISA and VISA Strains 125
AGR FUNCTIONALITY AND ABILITY TO FORM BIOFILM IN COL AND NRS149 STAPHYLOCOCCUS AUREUS 125
Antibacterial activity of Netilmicin and Netilmicin/Dexamethasone fixed combination against the most common ocular isolates 125
Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology and genomovar status 125
Detection of the IncX3 plasmid carrying blaKPC-3in a Serratia marcescens strain isolated from a kidney-liver transplanted patient 124
COLRAcinetobacter baumannii sRNA Signatures: Computational Comparative Identification and Biological Targets 124
Colistin resistance onset strategies and genomic mosaicism in clinical acinetobacter baumannii lineages 124
In vitro study of dactimicin (ST 900) against methicillin-susceptible and -resistant staphylococci. 123
In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cef ixime, in comparison with other drugs, against Haemophilus influenzae, haemophilus parainfluenzae, moraxella catarrhalis and streptococcus pneumoniae 123
Gold standard susceptibility testing of fosfomycin in Staphylococcus aureus and Enterobacterales using a new agar dilution panel® 123
Complex Systems Biology: Structural, Functional and Pathological Genomics of the Apoptotic Machinery and Identification of Candidate Genes for Breast Adenocarcinoma, Thyroid Carcinoma and Neuroblastoma 122
Totale 15.213
Categoria #
all - tutte 166.884
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 166.884


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021153 0 0 0 0 0 0 0 0 0 0 0 153
2021/20223.612 428 497 31 60 538 39 504 108 374 50 95 888
2022/20235.690 539 186 111 533 550 1.016 37 885 1.423 50 264 96
2023/20242.627 147 384 111 184 113 500 58 133 34 91 486 386
2024/202510.075 150 1.393 634 463 2.246 996 449 420 849 1.005 643 827
2025/202621.495 1.338 1.092 3.891 1.417 3.369 3.889 2.754 549 946 1.181 613 456
Totale 50.434